80 related articles for article (PubMed ID: 20811985)
1. Lentiviral vectors to study the differential function of ERK1 and ERK2 MAP kinases.
Indrigo M; Papale A; Orellana D; Brambilla R
Methods Mol Biol; 2010; 661():205-20. PubMed ID: 20811985
[TBL] [Abstract][Full Text] [Related]
2. Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes.
Wang X; Li F; Fan C; Wang C; Ruan H
Int J Mol Med; 2011 Apr; 27(4):583-9. PubMed ID: 21305249
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
Bessard A; Frémin C; Ezan F; Fautrel A; Gailhouste L; Baffet G
Oncogene; 2008 Sep; 27(40):5315-25. PubMed ID: 18521085
[TBL] [Abstract][Full Text] [Related]
4. Analysis of isoform specific ERK signaling on the effects of interleukin-1β on COX-2 expression and PGE2 production in human chondrocytes.
Wang X; Li F; Fan C; Wang C; Ruan H
Biochem Biophys Res Commun; 2010 Nov; 402(1):23-9. PubMed ID: 20883667
[TBL] [Abstract][Full Text] [Related]
5. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially.
Vantaggiato C; Formentini I; Bondanza A; Bonini C; Naldini L; Brambilla R
J Biol; 2006; 5(5):14. PubMed ID: 16805921
[TBL] [Abstract][Full Text] [Related]
6. The complexity of ERK1 and ERK2 MAPKs in multiple hepatocyte fate responses.
Frémin C; Ezan F; Guegan JP; Gailhouste L; Trotard M; Le Seyec J; Rageul J; Theret N; Langouët S; Baffet G
J Cell Physiol; 2012 Jan; 227(1):59-69. PubMed ID: 21437905
[TBL] [Abstract][Full Text] [Related]
7. Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2.
Mehdizadeh A; Somi MH; Darabi M; Farajnia S; Akbarzadeh A; Montazersaheb S; Yousefi M; Bonyadi M
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1612-1619. PubMed ID: 28058860
[TBL] [Abstract][Full Text] [Related]
8. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
[TBL] [Abstract][Full Text] [Related]
9. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.
Meloche S; Pouysségur J
Oncogene; 2007 May; 26(22):3227-39. PubMed ID: 17496918
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
11. Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation.
Voisin L; Saba-El-Leil MK; Julien C; Frémin C; Meloche S
Mol Cell Biol; 2010 Jun; 30(12):2918-32. PubMed ID: 20368360
[TBL] [Abstract][Full Text] [Related]
12. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
Li J; Johnson SE
Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
[TBL] [Abstract][Full Text] [Related]
13. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.
Dimitri CA; Dowdle W; MacKeigan JP; Blenis J; Murphy LO
Curr Biol; 2005 Jul; 15(14):1319-24. PubMed ID: 16051177
[TBL] [Abstract][Full Text] [Related]
14. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
Wei F; Xie Y; Tao L; Tang D
Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
[TBL] [Abstract][Full Text] [Related]
15. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells.
Mohankumar KM; Xu XQ; Zhu T; Kannan N; Miller LD; Liu ET; Gluckman PD; Sukumar S; Emerald BS; Lobie PE
Oncogene; 2007 Jun; 26(27):3998-4008. PubMed ID: 17213808
[TBL] [Abstract][Full Text] [Related]
16. ERK1/2 mediates unbalanced growth leading to senescence induced by excess thymidine in human cells.
Kobayashi Y; Lee SS; Arai R; Miki K; Fujii M; Ayusawa D
Biochem Biophys Res Commun; 2012 Sep; 425(4):897-901. PubMed ID: 22902634
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the inducible nuclear dual-specificity phosphatase DUSP5 by ERK MAPK.
Kucharska A; Rushworth LK; Staples C; Morrice NA; Keyse SM
Cell Signal; 2009 Dec; 21(12):1794-805. PubMed ID: 19666109
[TBL] [Abstract][Full Text] [Related]
19. Localization and trafficking of fluorescently tagged ERK1 and ERK2.
Marchi M; Parra R; Costa M; Ratto GM
Methods Mol Biol; 2010; 661():287-301. PubMed ID: 20811990
[TBL] [Abstract][Full Text] [Related]
20. Functional Redundancy of ERK1 and ERK2 MAP Kinases during Development.
Frémin C; Saba-El-Leil MK; Lévesque K; Ang SL; Meloche S
Cell Rep; 2015 Aug; 12(6):913-21. PubMed ID: 26235619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
